Navidea Biopharmaceuticals Inc RPE

RPE a Health Care szektor a NYSEMKT-on cégekben a Navidea Biopharmaceuticals Inc -hoz képest

Mit csinál Navidea Biopharmaceuticals Inc?

navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de

rpe -hoz hasonló cégek Navidea Biopharmaceuticals Inc

• Keros Therapeutics nak RPE $4.517k van
• Progenity nak RPE $4.706k van
• Geron nak RPE $4.718k van
• PureTech Health plc nak RPE $4.926k van
• IMV nak RPE $4.959k van
• Deinove SA nak RPE €5.020k van
• Navidea Biopharmaceuticals Inc nak RPE $5.050k van
• Windtree Therapeutics nak RPE $5.097k van
• Collaborate nak RPE AUD$5.143k van
• Bardoc Gold nak RPE AUD$5.210k van
• At Home Inc nak RPE $5.211k van
• Xeros Technology Plc nak RPE £5.244k van
• ImmuPharma Plc nak RPE £5.268k van